NASDAQ:GILD
Gilead Stock News
$64.92
-0.540 (-0.82%)
At Close: May 08, 2024
3 Analyst Upgrades That Smart Investors Won't Ignore
01:29pm, Wednesday, 17'th May 2023
Even the most experienced investors have only so many hours in the day to perform their due diligence. That's where analyst ratings can be helpful.
GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?
10:22am, Tuesday, 16'th May 2023
Gilead Sciences (NASDAQ: GILD ) stock is a hot topic on Tuesday as a new price prediction builds enthusiasm among investors. BMO Capital Markets analyst Evan David Seigerman is behind today's news as
Gilead Sciences, Inc. (GILD) Presents at BofA Securities 2023 Health Care Conference (Transcript)
07:10pm, Saturday, 13'th May 2023
Gilead Sciences, Inc. (NASDAQ:GILD ) BofA Securities 2023 Health Care Conference May 9, 2023 2:20 PM ET Company Participants Andy Dickinson - CFO Conference Call Participants Geoff Meacham - Bank of A
Gilead Sciences Stock: Bear vs. Bull
05:30am, Friday, 12'th May 2023
Declining sales of certain drugs, including coronavirus treatment Veklury, has weighed on Gilead's earnings. Still, Gilead is the world's leader in HIV treatments -- and new products across treatment
Gilead Sciences didn't violate government patents on HIV prevention treatment, jury finds
12:43pm, Tuesday, 09'th May 2023Final Trades: Chevron, American Express & Gilead
03:02pm, Friday, 05'th May 2023
The "Halftime Report" traders give their top picks to watch for the second half.
2 Magnificent Dividend Stocks to Buy Before the Next Recession
09:45am, Friday, 05'th May 2023
Both of these drugmakers have rich pipelines that will allow them to recover from recent sales slumps. They also offer above-average dividend yields and have raised their payouts regularly over the la
Gilead Sciences Stock Has Only Done This in 1 of the Past 7 Years
07:50am, Thursday, 04'th May 2023
Gilead Sciences stock hasn't been a good investment in recent years, often underperforming the S&P 500. Declining revenue and a lack of a growth catalyst has made investors bearish on the stock.
Gilead Sciences battles U.S. government in court over HIV prevention patent
02:46pm, Tuesday, 02'nd May 2023
The U.S. claims Gilead's drugs Truvada and Descovy infringe on CDC patents.
Gilead Sciences: A Mixed First Quarter
05:43am, Monday, 01'st May 2023
Gilead Sciences saw strong sales growth in the first quarter. While sales were strong, margins took quite a substantial beating.
Gilead's (GILD) Q1 Earnings Miss, Veklury Sales Plunge
02:26pm, Friday, 28'th Apr 2023
Gilead's (GILD) Q1 earnings and sales miss estimates due to lower Veklury sales.
Gilead shares fall after mixed results, as weaker COVID-19 drug remand weighs
05:18pm, Thursday, 27'th Apr 2023
Gilead Sciences Inc. on Thursday cut one of its profit forecasts and reported first-quarter profit that missed expectations, with weaker demand for its COVID-19 drug weighing on results, sending share
Gilead Earnings Fall Short as Demand for Covid-19 Meds Sink
04:05pm, Thursday, 27'th Apr 2023
Gilead Sciences reported mixed first-quarter financial results on Thursday afternoon, as sales of its cancer and HIV drugs rose, while sales of its Covid-19 antiviral fell.
Better Buy: Pfizer vs. Gilead
05:30am, Thursday, 27'th Apr 2023
Pfizer and Gilead are both facing declines in demand for their coronavirus products. These big-pharma players bring in blockbuster revenue from other products, too -- and the future looks bright.
Drug/Biotech Stocks' Q1 Earnings Due Apr 27: LLY, ABBV & More
10:40am, Wednesday, 26'th Apr 2023
Let's look at the five biotech/pharma companies slated to release quarterly results on Apr 27.
